CLINICAL_TRIALS
trial_result
· 2025-10-20
Clinical Trial Update: A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF]) [Phase 2]
Summary
Phase 2 dose-ranging trial of OPC-131461 in congestive heart failure (cardiac edema) completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cardiac Edema (CHF) | Phase 2 | Status: COMPLETED | Results posted: 2025-10-20